E-LIB Suche - Ergebnisse für: Sharon, E

1

Final Result of DIAL (NCI10089), Randomized Phase 2 trial o..:

Soekojo, C. Y. ; Yin, J. ; Kline, J....
Hematological Oncology. 41 (2023) S2 - p. 592-594 , 2023

Link: https://doi.org/10.1002/..

2

P1.27-04 Phase II Basket Trial of Dual Anti-CTLA-4 and Anti..:

Chae, Y.K. ; Othus, M. ; Patel, S.P....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S284-S285 , 2023

Link: https://doi.org/10.1016/..

3

HSD81 Trends in Systemic Therapy Utilization Among Older Pa..:

Hong, Y.D. ; Enewold, L. ; Sharon, E....
Value in Health. 26 (2023) 6 - p. S252 , 2023

Link: https://doi.org/10.1016/..

4

OA02.04 Phase 1/2 Randomized Trial of Anetumab Ravtansine a..:

Mansfield, A.S. ; Yin, J.V. ; Bradbury, P....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S47 , 2023

Link: https://doi.org/10.1016/..

5

49MO Atezolizumab and bevacizumab in patients treated with ..:

Chen, A. ; Sharon, E. ; Van Tine, B.A....
ESMO Open. 8 (2023) 1 - p. 101086 , 2023

Link: https://doi.org/10.1016/..

6

Physica status solidi

Volume 65, Number 1: 16. Mai Physica status solidi ; Volume 65, Number 1, A

Aczel, O. F. G ; Akhmetov, V. D ; Alperovich, V. L... - Reprint 2021 . , [2022]

Link: https://doi.org/10.1515/..

7

Crizotinib in patients with tumors harboring ALK or ROS1 re..:

Mansfield, A. S. ; Wei, Z. ; Mehra, R....
npj Precision Oncology. 6 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

8

Role of Adjuvant Regional Nodal Irradiation in Resected Mel..:

Bhandari, M. ; Othus, M. ; Kirkwood, J....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. S82-S83 , 2022

Link: https://doi.org/10.1016/..

9

Abstract #4317 Peri-operative novel psychological intervent..:

Hanalis-Miller, T. ; Ricon, I. ; Haldar, R....
Brain, Behavior, and Immunity. 81 (2019) - p. 29 , 2019

Link: https://doi.org/10.1016/..

10

A phase II study of atezolizumab in combination with bevaci..:

Friedman, C.F. ; Snyder, A. ; Sharon, E....
Gynecologic Oncology. 154 (2019) - p. 17-18 , 2019

Link: https://doi.org/10.1016/..

11

THE DIAL STUDY (DUAL IMMUNOMODULATION IN AGGRESSIVE LYMPHOM..:

Villasboas, J.C. ; Reeder, C.B. ; Tun, H.W....
Hematological Oncology. 37 (2019) S2 - p. 70-71 , 2019

Link: https://doi.org/10.1002/..

12

Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amp..:

Jhaveri, K.L. ; Wang, X.V. ; Makker, V....
Annals of Oncology. 30 (2019) 11 - p. 1821-1830 , 2019

Link: https://doi.org/10.1093/..

13

Interim safety analysis of cancer immunotherapy trials Netw..:

Uldrick, T.S. ; 'Mac' Cheever, M.A. ; Gonçalves, P.H....
Journal of Virus Eradication. 3 (2017) - p. 55-56 , 2017

Link: https://doi.org/10.1016/..

14

Psychological and/or pharmacological short perioperative in..:

Ricon, I. ; Hanalis-Miller, T. ; Haldar, R....
Brain, Behavior, and Immunity. 66 (2017) - p. e15 , 2017

Link: https://doi.org/10.1016/..

15

Abstract # 1731 Perioperative COX-2 inhibition and beta-adr..:

Shaashua, L. ; Shabat-Simon, M. ; Haldar, R....
Brain, Behavior, and Immunity. 57 (2016) - p. e8 , 2016

Link: https://doi.org/10.1016/..